To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
About This Bill
Committee
Latest Action · January 23, 2025
Referred to the House Committee on Energy and Commerce.